This is a England news story, published by BBC, that relates primarily to NHS news.
For more England news, you can click here:
more England newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from BBC, you can click here:
more news from BBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Other osteoporosis treatments. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest bone health news, bone strength news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
osteoporosisBBC
•
76% Informative
Abaloparatide can protect against the bone-thinning condition called osteoporosis.
It will become available on the NHS in England within the next three months .
By the time people are in their mid-20s , bone strength will have peaked.
Oestrogen levels drop, which can weaken the bones.
VR Score
74
Informative language
70
Neutral language
86
Article tone
informal
Language
English
Language complexity
47
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links